Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

3.96
Delayed Data
As of May 22
 +0.02 / +0.51%
Today’s Change
1.89
Today|||52-Week Range
5.10
+33.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$324.8M

Company Description

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. The company has three drug candidates in development: Firdapse, CPP-115 and CPP-109. Catalyst Pharmaceutical Partners was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.

Contact Information

Catalyst Pharmaceutical Partners, Inc.
355 Alhambra Circle
Coral Gables Florida 33134
P:(305) 529-2522
Investor Relations:

Employees

Shareholders

Other institutional36.49%
Individual stakeholders17.20%
Mutual fund holders11.33%

Top Executives

Patrick J. McEnanyChairman, President & Chief Executive Officer
Steven R. MillerChief Operating & Scientific Officer
Alicia GrandeChief Financial Officer, Treasurer & VP
Charles W. GorodetzkyChief Medical Officer
Bernardino MosqueraVice President-Clinical Operations

To view my watchlist

Not a member yet?

Sign up now for a free account